Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome

Sleep Medicine Reviews

Volumn 12, Issue 1, 2008, Pages 49-63

  Riha, Renata L ^a   Diefenbach, Konstanze ^b   Jennum, Poul ^c   McNicholas, Walter T ^d  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Genetics; Hypertension; Inflammation; Metabolic syndrome; Sleep apnoea

Indexed keywords

BREATHING DISORDER; CARDIOVASCULAR DISEASE; GENE MAPPING; GENOME; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTENSION; METABOLIC DISORDER; PHENOTYPE; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDER;

CHROMOSOME MAPPING; CONTINUOUS POSITIVE AIRWAY PRESSURE; GENE EXPRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; MULTIFACTORIAL INHERITANCE; PHENOTYPE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 38049061330     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2007.08.004     Document Type: Review

References (132)

1. Tishler P.V., Larkin E.K., Schluchter M.D., and Redline S. Incidence of sleep-disordered breathing in an adult urban population. JAMA 289 (2003) 2230-2237
2. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165 (2002) 1217-1239
3. Shamsuzzaman A.S., Gersh B.J., and Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290 (2003) 1906-1914
4. Anonymous. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22 (1999) 667-689
5. Duran J., Esnaola S., Rubio R., and Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 163 (2001) 685-689
6. Bixler E.O., Vgontzas A.N., Lin H.M., et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163 (2001) 608-613
7. Redline S., and Tishler P.V. The genetics of sleep apnea. Sleep Med Rev 4 6 (2000) 583-602
8. Schwab R.J., Pasirstein M., Kaplan L., Pierson R., Mackley A., Hachadoorian R., et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med 173 4 (2006) 453-463
9. Riha R.L., Brander P., Vennelle M., and Douglas N.J. A cephalometric comparison of patients with the sleep apnea/hypopnea syndrome and their siblings. Sleep 28 3 (2005) 315-320
10. Jordan A.S., Wellman A., Edwards J.K., Schory K., Dover L., MacDonald M., et al. Respiratory control stability and upper airway collapsibility in men and women with obstructive sleep apnea. J Appl Physiol 99 5 (2005) 2020-2027
11. Mohsenin V. Gender differences in the expression of sleep-disordered breathing: role of upper airway dimensions. Chest 120 5 (2001) 1442-1447
12. Riha R.L. Genetics of the sleep apnoea/hypopnoea syndrome. Somnologie 10 (2006) 101-112
13. Redline S., Tishler P.V., Hans M.G., Tosteson T.D., Strohl K.P., and Spry K. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 155 1 (1997) 186-192
14. Rajagopal K.R., Abbrecht P.H., and Tellis C.J. Control of breathing in obstructive sleep apnea. Chest 85 2 (1984) 174-180
15. Javaheri S., Colangelo G., Corser B., and Zahedpour M.R. Familial respiratory chemosensitivity does not predict hypercapnia of patients with sleep apnoea-hypopnea syndrome. Am Rev Respir Dis 145 4 Part 1 (1992) 837-840
16. Gold A.R., Schwartz A.R., Wise R.A., and Smith P.L. Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest 103 5 (1993) 1325-1329
17. Narkiewiez K., van de Borne P.J., Pesek C.A., Dyken ME Montano N., and Somers V.K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99 9 (1999) 1183-1189
18. Marcus C.L., Gozal D., Arens R., Basinki D.J., Omlin K.J., Keens T.G., et al. Ventilatory responses during wakefulness in children with obstructive sleep apnea. Am J Respir Crit Care Med 149 3 Part 1 (1994) 715-721
19. Radwan L., Koziorowski A., Maszczyk Z., Plywaezewski R., Boros P., Franczuk M., et al. Respiratory response to inspiratory resistive load changes in patients with obstructive sleep apnea syndrome. Pneumonol Alergol Pol 68 1-2 (2000) 44-56
20. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 3 (1995) 241-247
21. Daly A.K., and Day C.P. Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 52 5 (2001) 489-499
22. Faccenda J.F., MacKay T.W., Boon N.A., and Douglas N.J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 2 (2001) 344-348
23. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 9302 (2002) 204-210
24. Dyken M.E., Somers V.K., Yamada T., Ren Z.Y., and Zimmerman M.B. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 27 3 (1996) 401-407
25. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 19 (2000) 1378-1384
26. **The most important references are denoted by an asterisk. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
27. Doherty L.S., Kiely J.L., Swan V., and McNicholas W.T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 127 (2005) 2076-2084
28. Munroe P.B., et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension 48 (2006) 105-111
29. *. Samani N.J. Genome scans for hypertension and blood pressure regulation. Am J Hypertens 16 (2003) 167-171
30. *. Liu W., Zhao W., and Chase G.A. Genome scan meta-analysis for hypertension. Am J Hypertens 17 (2004) 1100-1106
31. Cowley A.W. The genetic dissection of essential hypertension. Nat Rev 7 (2006) 829-840
32. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
33. Faller D.V. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 26 1 (1999) 74-84
34. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 1 (1990) 22-27
35. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 8828 (1992) 1111-1115
36. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., and Celermajer D.S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61 (2006) 491-495
37. Cross MD, Mills NP, Al-Abri M, Riha RL, Vennelle M, Newby DE, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnea-hypopnea syndrome: a randomised placebo controlled trial, in submission.
38. Hui D.S., To K.W., Ko F.W., Fok J.P., Chan M.C., Ngai J.C., et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 6 (2006) 1083-1090
39. Kraiczi H., Peker Y., Caidahl K., Samuelsson A., and Hedner J. Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens 19 11 (2001) 2071-2078
40. Kraiczi H., Caidahl K., Samuelsson A., Peker Y., and Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119 4 (2001) 1085-1091
41. Kraiczi H., Hedner J., Peker Y., and Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 89 2 (2000) 493-498
42. Kato M., Roberts-Thomson P., Phillips B.G., Haynes W.G., Winnicki M., Accurso V., et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102 21 (2000) 2607-2610
43. Duchna H.W., Guilleminault C., Stoohs R.A., Faul J.L., Moreno H., Hoffman B.B., et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 161 1 (2000) 187-191
44. Grote L., Kraiczi H., and Hedner J. Reduced a. Am J Respir Crit Care Med 162 4 Part 1 (2000) 1480-1487
45. Ip M.S., Lam B., Chan L.Y., Zheng L., Tsang K.W., Fung P.C., et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162 6 (2000) 2166-2171
46. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 1 (2004) 123-128
47. Minoguchi K., Yokoe T., Tanaka A., Ohta S., Hirano T., Yoshino G., et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J 28 2 (2006) 378-385
48. *. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7 1 (2003) 35-51
49. Lavie L., Lotan R., Hochberg I., Herer P., Lavie P., and Levy A.P. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep 26 5 (2003) 592-595
50. Schulz R., Hummel C., Heinemann S., Seeger W., and Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165 1 (2002) 67-70
51. Gozal D., Lipton A.J., and Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25 1 (2002) 59-65
52. Lavie L., Kraiczi H., Hefetz A., Ghandour H., Perelman A., Hedner J., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165 12 (2002) 1624-1628
53. Grimpen F., Kanne P., Schulz E., Hagenah G., Hasenfuss G., and Andreas S. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J 15 2 (2000) 320-325
54. Saarelainen S., and Hasan J. Circulating endothelin-1 and obstructive sleep apnoea. Eur Respir J 16 1 (2000) 187-188
55. Phillips B.G., and Somers V.K. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea. Respir Physiol 119 2-3 (2000) 181-187
56. Zhang J., Zhao B., Gesongluobu, Sun Y., Wu Y., Pei W., et al. Angiotensin-converting enzyme gene insertion/deletion (I/D) polymorphism in hypertensive patients with different degrees of obstructive sleep apnea. Hypertens Res 23 5 (2000) 407-411
57. Lin L., Finn L., Zhang J., Young T., and Mignot E. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med 170 12 (2004) 1349-1353
58. Patel S.R., Larkin E.K., Mignot E., Lin L., and Redline S. The Association of Angiotensin Converting Enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 30 (2007) 531-533
59. Bostrom K.B., Hedner J., Melander O., Grote L., Gullberg B., Rastam L., et al. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 25 4 (2007) 779-783
60. Bartels N.K., Borgel J., Wieczorak S., et al. Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of b2-adrenergic receptor polymorphisms. BMC Med 5 (2007) 1
61. *. McNicholas W.T., Bonsignore M.R., and Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29 1 (2007) 156-178
62. *. Navarro-Antolin J., Levitsky K.L., Calderon E., Ordonez A., and Lopez-Barneo J. Decreased expression of maxi-K+ channel beta1-subunit and altered vasoregulation in hypoxia. Circulation 112 9 (2005) 1309-1315
63. Williams A., and Scharf S.M. Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF-kappaB the key?. Sleep Breath (2007) [Epub ahead of print]
64. McNicholas W.T., and Ryan S. Obstructive sleep apnoea syndrome: translating science to clinical practice. Respirology 11 (2006) 136-144
65. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
66. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 21 Suppl. 1 (2004) II2-II10
67. Yokoe T., Minoguchi K., Matsuo H., Oda N., Minoguchi H., Yoshino G., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
68. Ohga E., Tomita T., Wada H., Yamamoto H., Nagase T., and Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94 (2003) 179-184
69. Minoguchi K., Tazaki T., Yokoe T., Minoguchi H., Watanabe Y., Yamamoto M., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126 (2004) 1473-1479
70. *. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174 7 (2006) 824-830
71. Das U.N. Is obesity an inflammatory condition?. Nutrition 17 (2001) 953-966
72. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., Wolk R., Kara T., Accurso V., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 21 (2002) 2462-2464
73. Kokturk O., Ciftci T.U., Mollarecep E., and Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46 5 (2005) 801-809
74. Barcelo A., Barbe F., Llompart E., Mayoralas L.R., Ladaria A., Bosch M., et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 117 2 (2004) 118-121
75. Guilleminault C., Kirisoglu C., and Ohayon M.M. C-reactive protein and sleep-disordered breathing. Sleep 27 8 (2004) 1507-1511
76. Akashiba T., Akahoshi T., Kawahara S., Majima T., and Horie T. Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med 44 8 (2005) 899-900
77. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
78. *. Ryan S., Nolan G., Hannigan E., Cunningham S., Taylor C.T., and McNicholas W.T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax (2007) [Epub ahead of print]
79. Bunn H.F., and Poyton R.O. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76 3 (1996) 839-885
80. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96 3 (2004) 1173-1177 discussion 1170-2
81. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 17 (2005) 2660-2667
82. Ohga E., Tomita T., Wada H., Yamamoto H., Nagase T., and Ouchi Y. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87 (1999) 10-14
83. Dyugovskaya L., Lavie P., and Lavie L. Phenotypic and functional characterization of blood gamma delta T cells in sleep apnea. Am J Respir Crit Care Med 168 (2003) 242-249
84. Pober J.S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 131 (1987) 170-184
85. Kritchevsky S.B., Cesari M., and Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66 (2005) 265-275
86. Riha R.L., Brander P., Vennelle M., McArdle N., Kerr S.M., Anderson N.H., et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 26 (2005) 673-678
87. van Zwieten P.A., and Mancia G. The metabolic syndrome-a therapeutic challenge. Van Zuiden Communications (2007)
88. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 3 (2002) 356-359
89. Sale M.M., Woods J., and Freedman B.I. Genetic determinants of the metabolic syndrome. Curr Hypertens Rep 8 1 (2006) 16-22
90. *. Kraja A.T., Hunt S.C., Pankow J.S., Myers R.H., Heiss G., Lewis C.E., et al. An evaluation of the metabolic syndrome in the HyperGEN study. Nutr Metab (Lond) 2 (2005) 2
91. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., and Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (1992) 715-722
92. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care 24 (2001) 683-689
93. Lee W.-J., Huang M.-T., Wang W., Lin C.-M., Chen T.-C., and Lai I.-R. Effects of obesity surgery on the metabolic syndrome. Arch Surg 139 (2004) 1088-1092
94. McLaughlin T., Allison G., Abbasi F., Lamendola C., and Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 53 (2004) 495-499
95. von Eyben F.E., Mouritsen E., Holm J., Montvilas P., Dimcevski G., Suciu G., et al. Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 27 (2003) 941-949
96. Hong Y., Rice T., Gagnon J., Despres J.P., Nadeau A., Perusse L., et al. Familial clustering of insulin and abdominal visceral fat: the HERITAGE Family Study. J Clin Endocrinol Metab 83 12 (1998) 4239-4245
97. Meigs J.B., D'Agostino Sr. R.B., Wilson P.W., Cupples L.A., Nathan D.M., and Singer D.E. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46 10 (1997) 1594-1600
98. Katzmarzyk P.T., Perusse L., Malina R.M., Bergeron J., Despres J.P., and Bouchard C. Stability of indicators of the metabolic syndrome from childhood and adolescence to young adulthood: the Quebec Family Study. J Clin Epidemiol 54 2 (2001) 190-195
99. Bao W., Srinivasan S.R., Wattigney W.A., and Berenson G.S. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch Intern Med 154 16 (1994) 1842-1847
100. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., James R.G., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 97 26 (2000) 14478-14483
101. *. Das S.K., and Elbein S.C. The search for type 2 diabetes susceptibility loci: the chromosome 1q story. Curr Diab Rep 7 2 (2007) 154-164
102. Hoffmann K., Mattheisen M., Dahm S., Nurnberg P., Roe C., Johnson J., et al. A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 50 7 (2007) 1418-1422
103. Jacobson P., Rankinen T., Tremblay A., et al. Resting metabolic rate and respiratory quotient: results from a genome-wide scan in Quebec Family Study. Am J Clin Nutr 84 (2006) 1527-1533
104. Rich S.S., Bowden D.W., Haffner S.M., et al. A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 54 (2005) 290-295
105. Jowett J.B., Elliott K.S., Curran J.E., Hunt N., Walder K.R., Collier G.R., et al. Genetic variation in BEACON influences quantitative variation in metabolic syndrome-related phenotypes. Diabetes 53 9 (2004) 2467-2472
106. Bozaoglu K., Curran J.E., Elliott K.S., et al. Association of genetic variation within UBL5 with phenotypes of metabolic syndrome. Hum Biol 78 (2006) 147-159
107. Olivier M., Hsiung C.A., Chuang L.M., Ho L.T., Ting C.T., Bustos V.I., et al. Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity. Hum Mol Genet 13 17 (2004) 1885-1892
108. Hamid Y.H., Rose C.S., Urhammer S.A., Glumer C., Nolsoe R., Kristiansen O.P., et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48 2 (2005) 251-260
109. Steinle N.I., Kazlauskaite R., Imumorin I.G., Hsueh W.C., Pollin T.I., O'Connell J.R., et al. Variation in the lamin A/C gene: associations with metabolic syndrome. Arterioscler Thromb Vasc Biol 24 9 (2004) 1708-1713
110. Fernandez M.L., Ruiz R., Gonzalez M.A., Ramirez-Lorca R., Couto C., Ramos A., et al. Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost 92 2 (2004) 413-418
111. Dallongeville J., Helbecque N., Cottel D., Amouyel P., and Meirhaeghe A. The Gly16→Arg16 and Gln27→Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 88 10 (2003) 4862-4866
112. Robitaille J., Brouillette C., Houde A., Lemieux S., Perusse L., Tchernof A., et al. Association between the PPAR alpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 49 9 (2004) 482-489
113. Kondo H., Shimomura I., Matsukawa Y., et al. Association of adiponectin mutation with type2 diabetes: a candidate gene for the insulin resistance síndrome. Diabetes 51 (2002) 2325-2328
114. Lee Y.J., and Tsai J.C. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diab Care 25 6 (2002) 1002-1008
115. Cai G., Cole S.A., Freeland-Graves J.H., MacCluer J.W., Blangero J., and Comuzzie A.G. Principal component for metabolic syndrome risk maps to chromosome 4p in Mexican Americans: the San Antonio Family Heart Study. Hum Biol 76 5 (2004) 651-665
116. Loos R.J., Katzmarzyk P.T., Rao D.C., Rice T., Leon A.S., Skinner J.S., et al., HERITAGE Family Study. Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study. J Clin Endocrinol Metab 88 12 (2003) 5935-5943
117. Ng M.C., So W.Y., Lam V.K., Cockram C.S., Bell G.I., Cox N.J., et al. Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 53 10 (2004) 2676-2683
118. Arya R., Blangero J., Williams K., Almasy L., Dyer T.D., Leach R.J., et al. Factors of insulin resistance syndrome-related phenotypes are linked to geneticlocations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 51 3 (2002) 841-847
119. Langefeld C.D., Wagenknecht L.E., Rotter J.I., Williams A.H., Hokanson J.E., Saad M.F., et al., Insulin Resistance Atherosclerosis Study Family Study. Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 53 4 (2004) 1170-1174
120. Hamet P., Merlo E., Seda O., Broeckel U., Tremblay J., Kaldunski M., et al. Quantitative founder-effect analysis of French Canadian families identifiesspecific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet 76 5 (2005) 815-832
121. McQueen M.B., Bertram L., Rimm E.B., Blacker D., and Santangelo S.L. A QTL genome scan of the metabolic syndrome and its component traits. BMC Genet 4 Suppl. 1 (2003) S96
122. Olswold C., and de Andrade M. Localization of genes involved in the metabolic syndrome using multivariatelinkage analysis. BMC Genet 4 Suppl. 1 (2003) S57
123. Stein C.M., Song Y., Elston R.C., Jun G., Tiwari H.K., and Iyengar S.K. Structural equation model-based genome scan for the metabolic syndrome. BMC Genet 4 Suppl. 1 (2003) S99
124. Tang W., Miller M.B., Rich S.S., North K.E., Pankow J.S., Borecki I.B., et al., National Heart, Lung, and Blood Institute Family Heart Study. Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes 52 11 (2003) 2840-2847
125. Francke S., Manraj M., Lacquemant C., Lecoeur C., Lepretre F., Passa P., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10 24 (2001) 2751-2765
126. Palmer L.J., Buxbaum S.G., Larkin E., Patel S.R., Elston R.C., Tishler P.V., et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 72 2 (2003) 340-350
127. Palmer L.J., Buxbaum S.G., Larkin E.K., Patel S.R., Elston R.C., Tishler P.V., et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 169 12 (2004) 1314-1321
128. Saarelainen S., Lehtimaki T., Kallonen E., Laasonen K., Poussa T., and Nieminen M.M. No relation between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet 53 2 (1998) 147-148
129. Foley D.J., Masaki K., White L., and Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAMA 286 12 (2001) 1447-1448
130. Kadotani H., Kadotani T., Young T., Peppard P.E., Finn L., Colrain I.M., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 285 22 (2001) 2888-2890
131. Gottlieb D.J., DeStefano A.L., Foley D.J., Mignot E., Redline S., Givelber R.J., et al. ApoE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 24, 63 4 (2004) 664-668
132. Larkin E.K., Patel S.R., Redline S., Mignot E., Elston R.C., and Hallmayer J. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol 30 (2006) 101-110